Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.87+0.01 (+0.11%)
Close on Nov 13, 2026Market cap $457.97MP/E –Yield –
Helus Pharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
No operating income figures for Helus Pharma
Helus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?